This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08590/identifier/chemspider/
dctermshttp://purl.org/dc/terms/
n4http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB08590/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08590/identifier/pubchem-compound/
n14http://linked.opendata.cz/resource/drugbank/drug/DB08590/identifier/pubchem-substance/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08590/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08590
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB08590 n13:DB08590
dcterms:title
1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE
adms:identifier
n8:T12 n9:11987888 n11:10160361 n12:DB08590 n14:99445061
n5:IUPAC-Name
n6:271B3FE2-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B3FE8-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B3FE7-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B3FE4-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B3FE5-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B3FE6-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B3FE0-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B3FDE-363D-11E5-9242-09173F13E4C5 n6:271B3FE1-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B3FDF-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B3FEE-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B3FEF-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B3FE9-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B3FEA-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B3FEC-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B3FEB-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B3FED-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B3FF4-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B3FF6-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B3FF7-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B3FF3-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B3FF2-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B3FF5-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B3FE3-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B3FF0-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B3FF1-363D-11E5-9242-09173F13E4C5